Chih‐Cheng Lai

19.4k citations
444 papers · 12.0k indexed · 2 hit papers · h-index 44
Topics
Antibiotic Resistance in Bacteria (56 papers)COVID-19 Clinical Research Studies (49 papers)Respiratory Support and Mechanisms (40 papers)
Journals
Nature CommunicationsSHILAP Revista de lepidopterologíaPLoS ONE
Partner nations
TaiwanChinaUnited States

In The Last Decade

Chih‐Cheng Lai

421 papers receiving 11.7k citations

Hit Papers

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV...20202026202220242020202110002.0k3.0k4.0k

Peers

Chih‐Cheng Lai
Comparison fields: 5 of 201
  • Infectious Diseases 4.7k
  • Epidemiology 2.9k
  • Neurology 1.3k
  • Pulmonary and Respiratory Medicine 1.3k
  • Molecular Biology 1.3k
Replace Eleftherios Mylonakis with:
Eleftherios Mylonakis United States
Shan‐Chwen Chang Taiwan
Yi‐Wei Tang United States
Jaffar A. Al‐Tawfiq Saudi Arabia
Wen‐Chien Ko Taiwan
Alimuddin Zumla United Kingdom
Arthur Reingold United States
Yen‐Hsu Chen Taiwan
Vincent Chi‐Chung Cheng China
Po‐Ren Hsueh Taiwan
Chih‐Cheng Lai relative to Eleftherios Mylonakis United States Eleftherios Mylonakis's profile →
Citations per field
00.5×3.5×
Eleftherios Mylonakis · 1×
Citations per year

Countries citing papers authored by Chih‐Cheng Lai

Since Specialization
Citations

This map shows the geographic impact of Chih‐Cheng Lai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chih‐Cheng Lai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chih‐Cheng Lai more than expected).

Fields of papers citing papers by Chih‐Cheng Lai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chih‐Cheng Lai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chih‐Cheng Lai. The network helps show where Chih‐Cheng Lai may publish in the future.

Co-authorship network of co-authors of Chih‐Cheng Lai

This figure shows the co-authorship network connecting the top 25 collaborators of Chih‐Cheng Lai. A scholar is included among the top collaborators of Chih‐Cheng Lai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chih‐Cheng Lai. Chih‐Cheng Lai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 2
3 1
4 2
5 3
6 3
7 2
8 3
9 9
10 3
11 10
12 11
13 9
14 4
15 2
16 0
17 84
18 6
19 41
20 19

About Chih‐Cheng Lai

Chih‐Cheng Lai is a scholar working on Microbiology, Applied Microbiology and Biotechnology and Molecular Medicine, having authored 444 papers that have together received 12.0k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (56 papers), COVID-19 Clinical Research Studies (49 papers) and Respiratory Support and Mechanisms (40 papers). The work is most often cited by research in Microbiology (361 citations), Applied Microbiology and Biotechnology (537 citations) and Infectious Diseases (4.7k citations). Chih‐Cheng Lai has collaborated with scholars based in Taiwan, China and United States. Frequent co-authors include Po‐Ren Hsueh, Wen‐Chien Ko, Hung-Jen Tang, Chien‐Ming Chao, Yu‐Tsung Huang, Hung-Jen Tang, Chun‐Hsing Liao, Cheng‐Yi Wang, Ping‐Ing Lee and Ya‐Hui Wang. Their work appears in journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026